Search Articles

View query in Help articles search

Search Results (1 to 9 of 9 Results)

Download search results: CSV END BibTex RIS


Effectiveness of Virtual Reality Training in Improving Outcomes for Dialysis Patients: Systematic Review and Meta-Analysis

Effectiveness of Virtual Reality Training in Improving Outcomes for Dialysis Patients: Systematic Review and Meta-Analysis

Dialysis, encompassing both hemodialysis (HD) and peritoneal dialysis (PD), serves as a common therapeutic approach for ESRD, substituting renal filtration function albeit necessitating frequent hospital visits, significantly impacting patients’ lives. Prolonged dialysis treatment often precipitates complications such as anemia, muscle wasting, skeletal disorders, and cardiovascular ailments.

Xin Kang, Yiping Zhang, Chaonan Sun, Jiaxin Zhang, Zhe Che, Jinhui Zang, Rongzhi Zhang

J Med Internet Res 2025;27:e58384

Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study

Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study

Specifically, titers seem to decline substantially after 6 to 12 months in adult dialysis patients [10]. A limited number of studies with a longer follow-up period suggest a possible benefit of revaccination after 2 years [11,12]. Pneumonia is a leading cause of death in patients with end-stage chronic kidney disease (stage 5) treated with dialysis (CKD 5 D). Acknowledging that many infectious complications are vaccine-preventable, specific recommendations have been issued for patients at risk.

Sibylle Mellinghoff, Gero von Gersdorff, Caroline Bruns, Kerstin Albus, Vassiliki Dimitriou, Angela Steinbach, Mathias Schaller, Jörg Janne Vehreschild, Oliver A Cornely, Blasius Janusch Liss

JMIR Res Protoc 2023;12:e45712

Improving Kidney Outcomes in Patients With Nondiabetic Chronic Kidney Disease Through an Artificial Intelligence–Based Health Coaching Mobile App: Retrospective Cohort Study

Improving Kidney Outcomes in Patients With Nondiabetic Chronic Kidney Disease Through an Artificial Intelligence–Based Health Coaching Mobile App: Retrospective Cohort Study

Patients were excluded if (1) they or their relatives were unable to use a smartphone, (2) they intended to start dialysis or have a kidney transplant within the next 3 months, (3) there was a lack of baseline or follow-up data, or (4) they refused to communicate with the health coach team. Study participants were followed for at least 3 months after recruitment until death or the start of renal replacement therapy.

Wei Liu, Xiaojuan Yu, Jiangyuan Wang, Tianmeng Zhou, Ting Yu, Xuyong Chen, Shasha Xie, Fuman Han, Zi Wang

JMIR Mhealth Uhealth 2023;11:e45531

Optimization of the Chronic Kidney Disease–Peritoneal Dialysis App to Improve Care for Patients on Peritoneal Dialysis in Northeast Thailand: User-Centered Design Study

Optimization of the Chronic Kidney Disease–Peritoneal Dialysis App to Improve Care for Patients on Peritoneal Dialysis in Northeast Thailand: User-Centered Design Study

In 2008, the Thai government adopted the Peritoneal Dialysis First policy for renal replacement therapy under its universal health care coverage scheme, increasing access in low-resource settings, with approximately 21% of patients on peritoneal dialysis (PD) in northeast Thailand [4]. Patients on PD manage their PD at home manually or by using a PD cycler to deliver dialysate fluid through a catheter placed in the peritoneal cavity, where the fluid remains for several hours.

Eakalak Lukkanalikitkul, Sawinee Kongpetch, Wijittra Chotmongkol, Michael G Morley, Sirirat Anutrakulchai, Chavis Srichan, Bandit Thinkhamrop, Theenatchar Chunghom, Pongsai Wiangnon, Wilaiphorn Thinkhamrop, Katharine E Morley

JMIR Form Res 2022;6(7):e37291

A Web-Based, Provider-Driven Mobile App to Enhance Patient Care Coordination Between Dialysis Facilities and Hospitals: Development and Pilot Implementation Study

A Web-Based, Provider-Driven Mobile App to Enhance Patient Care Coordination Between Dialysis Facilities and Hospitals: Development and Pilot Implementation Study

For US patients receiving dialysis, who are hospitalized for an average of 9.5 days per year (associated with annual Medicare costs of approximately US $12 billion) [2], transitions between the outpatient dialysis facility and the hospital present unique challenges.

Laura C Plantinga, Courtney Hoge, Ann E Vandenberg, Kyle James, Tahsin Masud, Anjali Khakharia, Carol Gray, Bernard G Jaar, Janice P Lea, Christopher M O'Donnell, Richard Mutell

JMIR Form Res 2022;6(6):e36052

Usability Evaluation of a Tablet-Based Intervention to Prevent Intradialytic Hypotension in Dialysis Patients During In-Clinic Dialysis: Mixed Methods Study

Usability Evaluation of a Tablet-Based Intervention to Prevent Intradialytic Hypotension in Dialysis Patients During In-Clinic Dialysis: Mixed Methods Study

The most advanced stage of CKD is end-stage renal disease (ESRD) wherein dialysis or transplantation is required for survival. In 2017, 746,557 Americans had ESRD [3]. However, transplants are not an option for many patients due to their health status and limited organ supply. Hemodialysis is the most common form of therapy for ESRD, with over 500,000 (about 70%) of all dialysis patients treated by hemodialysis rather than alternative dialysis modalities [3].

Matthew A Willis, Leah Brand Hein, Zhaoxian Hu, Rajiv Saran, Marissa Argentina, Jennifer Bragg-Gresham, Sarah L Krein, Brenda Gillespie, Kai Zheng, Tiffany C Veinot

JMIR Hum Factors 2021;8(2):e26012

Chronic Kidney Disease in Tasmania: Protocol for a Data Linkage Study

Chronic Kidney Disease in Tasmania: Protocol for a Data Linkage Study

Much of this cost is associated with the use of kidney replacement therapy (KRT; dialysis or kidney transplants). Tasmania is the island state of Australia with a population of half a million people spread over 68,000 km2. The whole of Tasmania is classified as rural or remote with many people (37%) living in areas of high disadvantage. The median age is 42 years, which is 5 years older than the median for Australia [4].

Timothy Saunder, Alex Kitsos, Jan Radford, Kim Jose, Charlotte McKercher, Rajesh Raj, Nadine Wiggins, Brian Stokes, Matthew D Jose

JMIR Res Protoc 2020;9(9):e20160

Limitations of Existing Dialysis Diet Apps in Promoting User Engagement and Patient Self-Management: Quantitative Content Analysis Study

Limitations of Existing Dialysis Diet Apps in Promoting User Engagement and Patient Self-Management: Quantitative Content Analysis Study

Commercial dialysis diet apps scored 3.45 (SD 1.63) out of 12 for valuable features; Android-based dialysis diet apps (3.88, SD 1.59) contained more valuable features than did Apple i OS-based dialysis diet apps (2.33, SD 1.21), as shown in Table 1. The mean overall MARS score of commercial dialysis diet apps was 13.48 (SD 2.05) out of a total score of 25 (see Table 1). Android dialysis diet apps (14.04, SD 1.87) have better technical quality than Apple i OS apps (12.01, SD 1.92).

Jun-Hao Lim, Cordelia-Kheng-May Lim, Imliya Ibrahim, Jazlina Syahrul, Mohd Hazli Mohamed Zabil, Nor Fadhlina Zakaria, Zulfitri Azuan Mat Daud

JMIR Mhealth Uhealth 2020;8(6):e13808

A Patient Decision Aid App for Patients With Chronic Kidney Disease: Questionnaire Study

A Patient Decision Aid App for Patients With Chronic Kidney Disease: Questionnaire Study

This paper sheds light on the applicability of a patient decision aid (PDA), the Dialysis Guide (DG) [1], which is available as an app for mobile phones and is made in accordance with the International Patient Decision Aid Standards (IPDAS) [2]. The DG is for patients with chronic kidney disease facing the choice of dialysis modality. The DG is a further development of a PDA in paper format, currently used at four hospitals in Denmark [3].

Signe Bülow Therkildsen, Linda Houlind Hansen, Laura Emilie Dinesen Jensen, Jeanette Finderup

JMIR Form Res 2019;3(4):e13786